Incyte grants equity awards to CSO Patrick Mayes

Q: What equity awards did Incyte (INCY) grant to Patrick A. Mayes on July 16, 2026?

Incyte granted Patrick A. Mayes 5,916 RSUs, 25,538 stock options at $116.65 per share, and 14,790 performance shares on July 16, 2026 as part of his equity compensation package with multi‑year vesting and performance conditions.

Q: How do the new restricted stock units for Incyte (INCY) executive Patrick A. Mayes vest?

The 5,916 restricted stock units awarded to Patrick A. Mayes vest 25% each year over four years. According to the award terms, the RSUs are settled in shares of Incyte common stock on a one‑for‑one basis upon vesting.

Q: What are the key terms of the stock options Incyte (INCY) granted to Patrick A. Mayes?

Mayes received 25,538 employee stock options with an exercise price of $116.65 per share, expiring on July 15, 2036. The options vest in 37 installments, with 25% after one year and the remainder vesting monthly over three years.

Q: How are Incyte (INCY) performance shares for Patrick A. Mayes structured?

Mayes was granted 14,790 performance shares, each representing the right to receive up to 200% of one share of common stock. Shares are earned based on Incyte’s relative total shareholder return over a three‑year period starting January 1, 2026 and vest on the third anniversary of grant.

Q: What does the Form 4 for Incyte (INCY) indicate about Patrick A. Mayes’s equity compensation mix?

The Form 4 shows a mix of time‑vested RSUs, stock options with a fixed exercise price, and performance shares tied to relative total shareholder return, indicating both service‑based and performance‑based long‑term incentives in his compensation.

Mayes Patrick A reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Mayes Patrick A reported acquisition or exercise transactions in this Form 4 filing.

Incyte Corp EVP & Chief Scientific Officer Patrick A. Mayes received equity awards on July 16, 2026, including 5,916 restricted stock units vesting 25% annually over four years, 25,538 stock options at $116.65 per share expiring July 15, 2036, and 14,790 performance shares tied to relative total shareholder return over a three-year period. Following the RSU award, he directly holds 63,628 shares of common stock.

Insider Trade Summary

Grant/Award: 46,244 shares

Grant/Award 3 txns

Insider Mayes Patrick A

Role EVP & Chief Scientific Officer

Type	Security	Shares	Price	Value
Grant/Award	Performance Shares ^F3	14,790	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) ^F4	25,538	$0.00	$0.00
Grant/Award	Common Stock ^{F1, F2}	5,916	$0.00	$0.00

Holdings After Transaction: Performance Shares — 14,790 contracts (Direct); Employee Stock Option (right to buy) — 25,538 contracts (Direct); Common Stock — 63,628 shares (Direct)

Footnotes (4)

F1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2. Including the July 16, 2026 grant, this includes an aggregate of 74,327 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
F3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
F4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:

Key Figures

Restricted stock units granted: 5,916 shares Stock options granted: 25,538 options Option exercise price: $116.65 per share +5 more

8 metrics

Restricted stock units granted 5,916 shares RSU award to Patrick A. Mayes on July 16, 2026

Stock options granted 25,538 options Employee stock option grant on July 16, 2026

Option exercise price $116.65 per share Conversion or exercise price of employee stock options

Option expiration date July 15, 2036 Expiration date of the July 16, 2026 stock options

Performance shares granted 14,790 units Performance share award on July 16, 2026

Performance share payout cap 200% of one share Maximum common stock per performance share based on TSR results

Common shares held after RSU award 63,628 shares Direct common stock holdings following July 16, 2026 RSU grant

Shares issuable from unvested RSUs 74,327 shares Aggregate common shares issuable from previously reported unvested RSUs including this grant

Key Terms

restricted stock units ("RSUs"), Employee Stock Option (right to buy), performance shares, relative total shareholder return ("TSR"), +1 more

5 terms

restricted stock units ("RSUs") financial

"Represents award of restricted stock units ("RSUs") that will vest 25% annually"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Employee Stock Option (right to buy) financial

"Security title reported as Employee Stock Option (right to buy) with 25,538 options"

performance shares financial

"Each performance share represents the right to receive up to 200% of one share"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

relative total shareholder return ("TSR") financial

"Earned shares are based on the issuer's relative total shareholder return ("TSR")"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Incyte (INCY) grant to Patrick A. Mayes on July 16, 2026?

Incyte granted Patrick A. Mayes 5,916 RSUs, 25,538 stock options at $116.65 per share, and 14,790 performance shares on July 16, 2026 as part of his equity compensation package with multi‑year vesting and performance conditions.

How do the new restricted stock units for Incyte (INCY) executive Patrick A. Mayes vest?

The 5,916 restricted stock units awarded to Patrick A. Mayes vest 25% each year over four years. According to the award terms, the RSUs are settled in shares of Incyte common stock on a one‑for‑one basis upon vesting.

What are the key terms of the stock options Incyte (INCY) granted to Patrick A. Mayes?

Mayes received 25,538 employee stock options with an exercise price of $116.65 per share, expiring on July 15, 2036. The options vest in 37 installments, with 25% after one year and the remainder vesting monthly over three years.

How are Incyte (INCY) performance shares for Patrick A. Mayes structured?

Mayes was granted 14,790 performance shares, each representing the right to receive up to 200% of one share of common stock. Shares are earned based on Incyte’s relative total shareholder return over a three‑year period starting January 1, 2026 and vest on the third anniversary of grant.

How many Incyte (INCY) common shares does Patrick A. Mayes hold after these awards?

After the July 16, 2026 RSU award, Patrick A. Mayes directly holds 63,628 shares of Incyte common stock. A related footnote states that, including this grant, 74,327 shares are issuable from previously reported unvested restricted stock units.

What does the Form 4 for Incyte (INCY) indicate about Patrick A. Mayes’s equity compensation mix?

The Form 4 shows a mix of time‑vested RSUs, stock options with a fixed exercise price, and performance shares tied to relative total shareholder return, indicating both service‑based and performance‑based long‑term incentives in his compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/20/2026 - 04:10 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mayes Patrick A

(Last)

(First)

(Middle)

1801 AUGUSTINE CUT-OFF

(Street)

WILMINGTON

DELAWARE

19803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/16/2026		A		5,916⁽¹⁾	A	$0	63,628⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Shares	⁽³⁾	07/16/2026		A		14,790		⁽³⁾	07/16/2029	Common Stock	14,790	$0	14,790	D
Employee Stock Option (right to buy)	$116.65	07/16/2026		A		25,538		⁽⁴⁾	07/15/2036	Common Stock	25,538	$0	25,538	D

Explanation of Responses:

1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

2. Including the July 16, 2026 grant, this includes an aggregate of 74,327 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR